Description:
XMD16-5is a novel non-receptor tyrosine kinase TNK2 inhibitor (IC50 = 16 nM and 77 nM for D163E and R806Q mutant TNK2, respectively)
Molecular Formula:
C23H24N6O2
Canonical SMILES:
CN1C2=CC=CC=C2C(=O)NC3=CN=C(N=C31)NC4=CC=C(C=C4)N5CCC(CC5)O
InChI:
1S/C23H24N6O2/c1-28-20-5-3-2-4-18(20)22(31)26-19-14-24-23(27-21(19)28)25-15-6-8-16(9-7-15)29-12-10-17(30)11-13-29/h2-9,14,17,30H,10-13H2,1H3,(H,26,31)(H,24,25,27)
InChIKey:
AGLKBEPKKDHHKY-UHFFFAOYSA-N
Solubility:
DMSO: ≥ 29 mg/mL
Storage: Store in a cool and dry place (or refer to the Certificate of Analysis).
Synonyms:
2-[4-(4-hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; XMD-16-5; XMD 16-5; XMD165; XMD-165; XMD 165 Weitere Informationen finden Sie
hier